Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants

Pharmacogenetics and Genomics

Volumn 21, Issue 10, 2011, Pages 631-641

  Ménard, Vincent ^a   Eap, Olivier ^a   Roberge, Joannie ^a   Harvey, Mario ^a   Lévesque, Eric ^a   Guillemette, Chantal ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b Canada Research Department in Pharmacogenomics   (Canada)

Author keywords

alternative promoter; alternative splicing; glucuronosyltransferase; UDP glucuronosyltransferase; UGT2B7

Indexed keywords

GLUCURONOSYLTRANSFERASE 2B7; MESSENGER RNA PRECURSOR; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; ARTICLE; ENZYME ACTIVITY; EXON; GASTROINTESTINAL TRACT; GENE; GENE LOCUS; GLUCURONIDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; LIVER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SPLICING; RNA TRANSCRIPTION; TISSUE SPECIFICITY; UGT 2B7 GENE;

EID: 80052722448     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283498147     Document Type: Article

References (26)

1. Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet 2002; 3:662-673. (Pubitemid 34984255)
2. Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci 2007; 32:286-295. (Pubitemid 46874931)
3. Wang X, Jiang X. PTEN: a default gate-keeping tumor suppressor with a versatile tail. Cell Res 2008; 18:807-816.
4. Black DL. Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology. Cell 2000; 103:367-370.
5. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008; 456:470-476. (Pubitemid 352759009)
6. Keren H, Lev-Maor G, Ast G. Alternative splicing and evolution: diversification, exon definition and function. Nat Rev Genet 2010; 11:345-355.
7. Levesque E, Menard V, Laverdiere I, Bellemare J, Barbier O, Girard H, et al. Extensive splicing of transcripts encoding the bile acid-conjugating enzyme UGT2B4 modulates glucuronidation. Pharmacogenet Genomics 2010; 20:195-210.
8. Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C. Genetic diversity at the UGT1 locus is amplified by a novel 30 alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics 2007; 17:1077-1089. (Pubitemid 351339492)
9. Medina MW, Gao F, Ruan W, Rotter J, Krauss R. Alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase is associated with plasma low-density lipoprotein cholesterol response to simvastatin. Circulation 2008; 118:355-362.
10. Guillemette C, Levesque E, Harvey M, Bellemare J, Menard V. UGTgenomic diversity: beyond gene duplication. Drug Metab Rev 2010; 42:24-44.
11. Owens IS, Basu NK, Banerjee R. UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families. Methods Enzymol 2005; 400:1-22. (Pubitemid 43052412)
12. Levesque E, Girard H, Journault K, Lepine J, Guillemette C. Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus. Hepatology 2007; 45:128-138. (Pubitemid 46144372)
13. Bellemare J, Rouleau M, Harvey M, Tetu B, Guillemette C. Alternativesplicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines. Pharmacogenomics J 2010; 10:431-441.
14. Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C. Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos 2010; 38:1785-1789.
15. Bellemare J, Rouleau M, Harvey M, Guillemette C. Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions. J Biol Chem 2010; 285:3600-3607.
16. Damianov A, Black DL. Autoregulation of Fox protein expression to produce dominant negative splicing factors. RNA 2010; 16:405-416.
17. McElvaine AT, Mayo KE. A dominant-negative human growth hormonereleasing hormone (GHRH) receptor splice variant inhibits GHRH binding. Endocrinology 2006; 147:1884-1894.
18. Laitem C, Leprivier G, Choul-Li S, Begue A, Monte D, Larsimont D, et al. Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51. Oncogene 2009; 28:2087-2099.
19. Tan D,Walker AM. Short form 1b human prolactin receptor down-regulates expression of the long form. J Mol Endocrinol 2009; 44:187-194.
20. Levesque E, Turgeon D, Carrier JS, Montminy V, Beaulieu M, Belanger A. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry (Mosc) 2001; 40:3869-3881. (Pubitemid 32280423)
21. Innocenti F, Liu W, Fackenthal D, Ramirez J, Chen P, Ye X, et al. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Pharmacogenet Genomics 2008; 18:683-697.
22. Sun C, Di Rienzo A. UGT2B7 is not expressed in normal breast. Breast Cancer Res Treat 2009; 117:225-226.
23. Lepine J, Bernard O, Plante M, Tetu B, Pelletier G, Labrie F, et al. Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 2004; 89:5222-5232. (Pubitemid 39391472)
24. Belanger AS, Caron P, Harvey M, Zimmerman PA, Mehlotra RK, Guillemette C. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine. Drug Metab Dispos 2009; 37:1793-1796.
25. Thibaudeau J, Lepine J, Tojcic J, Duguay Y, Pelletier G, Plante M, et al. Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res 2006; 66:125-133. (Pubitemid 43166017)
26. Turgeon D, Carrier J, Levesque E, Hum D, Belanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroidmetabolizing UGT2B subfamily members. Endocrinology 2001; 142: 778-787. (Pubitemid 32222427)